Sermorelin vs mk-677: what reddit gets right and wrong

Last updated 2026-07-24

What are people actually asking when they search sermorelin vs mk-677 reddit?

Most people typing this into Google or Reddit's search bar aren't looking for a chemistry lesson. They want a straight answer: which one is safer, which one works better, and which one is worth the money and the needle (or the pill). The Reddit angle matters because forums like r/Peptides and r/Sarms are full of self-reported experiences, dosing logs, and bloodwork screenshots that people trust more than a pharma pamphlet, for better or worse. Here's the honest framing before we get into details: sermorelin and MK-677 both aim to raise growth hormone (GH) output, but they do it through different mechanisms, have different regulatory histories, and carry different risk profiles. Sermorelin is a growth-hormone-releasing hormone (GHRH) analog. MK-677 (ibutamoren) is a ghrelin mimetic, technically a growth hormone secretagogue, that's been studied clinically but was never approved as a drug in the US or elsewhere. If you want the deep background on sermorelin itself, including its old brand name and clinical use, see sermorelin.

How does sermorelin actually work in the body?

Sermorelin is a synthetic 29-amino acid peptide that mimics the first 29 amino acids of naturally occurring GHRH, the hormone your hypothalamus releases to tell your pituitary gland to make and release growth hormone. It binds to GHRH receptors on the pituitary, prompting a pulse of GH release, then it gets cleared from the body fairly quickly, with a half-life of roughly 10 to 20 minutes depending on the study ^[1]. Because it works upstream, at the level of the pituitary, sermorelin depends on your pituitary actually functioning. If your pituitary is damaged or your GH axis is already shut down for some other reason, sermorelin won't do much. That's actually a built-in safety feature: it can't force GH output past what your own gland is capable of producing, unlike direct HGH injections, which flood the system regardless of your natural feedback loops. Sermorelin was sold in the US under the brand name Geref, approved by the FDA in the early 1990s for diagnosing and treating specific growth hormone deficiency conditions. The manufacturer discontinued Geref for commercial reasons in the 2000s, not because of a safety recall or FDA action pulling it from shelves ^[2]. That distinction matters a lot when people online conflate 'discontinued' with 'banned' or 'unsafe.' Today, sermorelin is available almost exclusively through compounding pharmacies under a prescription, not as an FDA-approved packaged drug.

How does mk-677 (ibutamoren) actually work in the body?

MK-677 is not a peptide. It's a small molecule, taken orally, that mimics ghrelin (the 'hunger hormone') and binds to the ghrelin receptor (GHSR) in the pituitary and hypothalamus. This stimulates GH and IGF-1 release through a different pathway than sermorelin, and it also stimulates appetite, which is one reason bodybuilders and some patients with muscle wasting have been interested in it ^[3]. MK-677 was developed by pharmaceutical companies (originally Merck-affiliated research programs) and studied in trials for elderly adults with frailty, for GH deficiency, and for reversal of catabolic states, but it was never brought to market as an approved drug anywhere. A 2020 clinical trial in the Journal of Clinical Endocrinology & Metabolism-adjacent literature and earlier trials from the late 1990s and 2000s found MK-677 reliably raises GH and IGF-1 levels, but also raises fasting glucose and can worsen insulin sensitivity over sustained use ^[4]. Because it's not FDA approved for any indication, MK-677 sold online is sold as a 'research chemical,' which means there's no manufacturing oversight, no guaranteed purity, and no legal channel through a licensed pharmacy for human use. That's a meaningfully different sourcing situation than sermorelin, which, despite not being FDA-approved as a finished branded drug anymore, is dispensed through licensed, state-regulated compounding pharmacies with a prescription.

What does reddit actually say about sermorelin vs mk-677?

Scanning through threads on r/Peptides, r/Sarms, and similar communities over the past few years, a few patterns show up again and again, and they're worth taking with real skepticism since none of this is verified data. MK-677 users frequently report increased appetite (sometimes described as intense hunger), water retention or puffiness in the face and hands, and mild lethargy or 'GH hangover' when starting. Some report improved sleep quality, sometimes attributed to modest increases in slow-wave sleep, which does have some support in older sleep-architecture studies of ghrelin mimetics, though the effect size in those trials was modest and not universal ^[5]. Sermorelin threads tend to describe a gentler, more subtle effect: better sleep, mild fat loss over months, less noticeable water retention, but also less of a dramatic 'feeling' day to day, which some users find underwhelming compared to MK-677's more obvious appetite and sedation effects. A recurring complaint in sermorelin threads is the injection requirement itself: reconstituting lyophilized peptide, drawing up small volumes with an insulin syringe, and storing it refrigerated is more friction than swallowing a capsule. That convenience gap explains a good chunk of MK-677's popularity in amateur bodybuilding circles despite its weaker regulatory footing. None of this is clinical evidence. Reddit self-report is confounded by dose, product purity (a real issue for gray-market MK-677), diet, training, and plain placebo effect. Treat it as color, not proof.

Which one has better safety data: sermorelin or mk-677?

Sermorelin has the edge here, mostly because of its regulatory history. As Geref, it went through FDA clinical trials for approval, meaning there's a real, if dated, safety and pharmacokinetic record filed with the agency ^[2]. Reported side effects in that history are mostly injection site reactions, flushing, and occasional headache, dizziness, or nausea, consistent with what's described in more recent compounding pharmacy labeling guidance. MK-677's safety picture is murkier. Clinical trials studying it for GH deficiency and frailty in older adults found it consistently raised fasting glucose and HbA1c over trial periods of 1 to 2 years, raising legitimate concern about insulin resistance with chronic use ^[4]. A 2017 trial in JAMA Internal Medicine's related aging research also linked MK-677 to increased rates of congestive heart failure and hospitalization in frail elderly patients, though that population was already high risk, so the finding shouldn't be generalized carelessly to a healthy 35-year-old lifting weights ^[4]. Still, it's a real, published signal that shouldn't get waved away in a Reddit thread. Both compounds carry a common risk with any GH-axis stimulation: increased IGF-1 levels over time is associated, in unrelated contexts, with increased risk markers for certain cancers, though causality in low-dose peptide use hasn't been established either way. This is a 'we don't fully know' area, and anyone with a personal or family cancer history should raise it directly with a prescriber before starting either compound. For more on what's actually documented with extended sermorelin use, see sermorelin long-term side effects.

Sermorelin vs mk-677 vs hgh: how do all three actually compare?

This is the comparison most readers actually want, because HGH (direct recombinant human growth hormone) is the benchmark everyone measures peptides against. Here's the honest breakdown.

Is sermorelin or mk-677 more effective for muscle growth or fat loss?

Neither has strong, modern, controlled trial evidence for muscle growth or fat loss in healthy adults, and anyone telling you otherwise on Reddit is generalizing from small, dated, or industry-adjacent studies. What data exists mostly comes from studies in GH-deficient patients or frail elderly populations, not healthy adults chasing body composition changes. Sermorelin's original clinical trials focused on diagnosing GH deficiency and treating pediatric growth failure, not adult body composition ^[2]. MK-677's trials in the late 1990s and 2000s did show modest increases in lean body mass in elderly and GH-deficient populations, alongside the glucose and cardiac concerns already mentioned ^{[4] [4]}. There is no solid randomized trial in healthy young adults showing either compound reliably produces meaningful fat loss or muscle growth beyond what diet and training alone accomplish. If your goal is body composition change, the evidence-backed levers (caloric balance, resistance training, sleep, protein intake) still outperform anything documented for either peptide in a healthy population. That's not a marketing line, it's just where the actual research currently sits.

How are sermorelin and mk-677 dosed, and does that affect the comparison?

Sermorelin is typically dosed as a nightly subcutaneous injection, commonly in the range of 200 to 300 mcg for adults under compounding pharmacy protocols, timed before bed to work with the body's natural nocturnal GH pulse. Because it's injected and has a short half-life, timing and consistency matter a lot; missing doses or injecting at random times reduces the benefit people report. MK-677 is dosed orally, usually once daily, commonly cited in gray-market and research literature at doses around 10 to 25 mg, though there's no standardized, prescriber-verified dosing protocol since it isn't a prescribed pharmaceutical in the US. That absence of a real dosing standard is itself a risk factor: without a licensed pharmacy or prescriber involved, dose consistency and product purity are both unverified. If you're looking at sermorelin specifically and want dosing detail grounded in what compounding pharmacies and prescribers actually use, the sermorelin dosage chart and sermorelin dosage calculator walk through typical starting doses, titration, and how body weight and goals factor in.

Is mk-677 legal, and is sermorelin legal to buy online?

MK-677 sits in a legal gray zone in the US. It's not a controlled substance, but it's also not an FDA-approved drug for human use, which means it's typically sold labeled 'for research purposes only,' a phrase that's a legal fig leaf more than an honest description of how it's actually used by most buyers. The FDA has issued warning letters to companies marketing SARMs and related compounds like MK-677 for unapproved human use, underscoring the point that it's not sanctioned for consumption ^[6]. Sermorelin sits on firmer legal ground because it requires a prescription and is dispensed through licensed, state-regulated compounding pharmacies, operating under the same general oversight framework compounding pharmacies use for other prescribed medications. That doesn't make it FDA-approved (compounded drugs aren't individually approved the way Geref once was), but it does mean a licensed pharmacist and a prescriber are legally accountable parts of the chain, which is not true of a MK-677 vial bought from a website with no medical oversight at all. For anyone weighing where to actually get sermorelin if you decide to move forward, sermorelin peptide near me covers how to find a legitimate prescriber and compounding pharmacy relationship rather than an unregulated online seller.

What do reddit users say went wrong with mk-677 or sermorelin?

The most common complaint pattern across MK-677 threads is water retention and facial puffiness severe enough that users stop the compound after a few weeks. A second common thread is elevated fasting glucose showing up on routine bloodwork, sometimes surprising users who weren't tracking it, which lines up with the clinical trial signal mentioned earlier ^[4]. Sermorelin complaints skew toward slower, less dramatic results and the injection hassle. Some users report injection site redness or minor bruising, consistent with labeling for GHRH analogs generally. A smaller subset report headache or flushing shortly after injection, which usually resolves as the body adjusts. What's notably rare in both communities: reports of serious adverse events requiring hospitalization. That's reassuring on one hand, but it's also worth remembering that Reddit self-report has no formal adverse event tracking system behind it, unlike the FDA's MedWatch program, which is the actual mechanism for catching rare but serious drug reactions in the real world.

Should you actually choose sermorelin over mk-677?

If you're set on trying a GH-axis compound and you want the option with real regulatory history, prescriber oversight, and a self-limiting mechanism, sermorelin is the more defensible choice. It won't give you the appetite spike or the dramatic 'feeling' some MK-677 users describe, and that's arguably a feature, not a bug: subtler, slower changes track with a mechanism that respects your body's own feedback loops instead of overriding them. MK-677's oral convenience is real, and its clinical data on raising GH and IGF-1 is genuinely solid. But the glucose and cardiac signals from actual trials, combined with zero manufacturing oversight in how it's sold today, make it a harder compound to recommend without a doctor actively monitoring bloodwork. Sermorelin, through Sermorelin Co's provider-reviewed process, connects you with a licensed prescriber who evaluates whether it's appropriate for you, and prescriptions are filled through a licensed compounding pharmacy partner, not shipped from an unregulated research chemical seller. That's the practical difference between 'a Reddit thread told me to try this' and a compound handled the way prescription medicine actually should be.

What questions should you ask a prescriber before starting either one?

Bring bloodwork requests, more than enthusiasm. Ask for baseline IGF-1, fasting glucose, HbA1c, and a basic metabolic panel before starting either compound, then repeat testing at 3 and 6 months. Ask specifically what monitoring plan the prescriber uses for glucose changes, since that's the most consistently documented risk across this drug class ^{[4] [4]}. Ask what happens if IGF-1 rises above the normal reference range for your age, since chronically elevated IGF-1 is the parameter most tied to long-term uncertainty around cancer risk in unrelated research contexts. Ask how long a trial period makes sense before reassessing whether it's actually doing anything measurable for you, since both compounds tend to show gradual, not dramatic, changes. And ask, honestly, whether you're a good candidate at all. Sermorelin depends on a functioning pituitary; if you have a pituitary condition or you're over an age where GH decline is expected and unremarkable, the calculus changes. A good prescriber will say so instead of just writing the script.

Frequently asked questions

Is mk-677 stronger than sermorelin?

In terms of raising GH and IGF-1 levels, clinical trial data on MK-677 shows a reliable, measurable increase, arguably more consistent than sermorelin's milder pituitary stimulation. But 'stronger' isn't the same as 'better': MK-677 also carries more documented glucose and cardiac risk signals in trial populations, so the tradeoff matters more than the raw effect size.

Can you take sermorelin and mk-677 together?

Some Reddit users report stacking them, reasoning that hitting the GH axis through two different receptors (GHRH and ghrelin) might produce a bigger combined effect. There's no controlled clinical trial data on combining them, so any claimed added benefit is unverified. Combining two GH-axis stimulants also compounds unknowns around glucose and IGF-1, so this should only be considered under direct prescriber supervision, if at all.

Why do people prefer mk-677 over sermorelin on reddit?

Mostly convenience: MK-677 is an oral capsule, while sermorelin requires reconstituting and injecting daily. MK-677 also produces more noticeable short-term effects (appetite, sedation, water retention) that some users interpret as 'it's working,' even though noticeable side effects aren't the same as proven benefit.

Is sermorelin fda approved?

Sermorelin was FDA approved under the brand name Geref in the early 1990s for growth hormone deficiency diagnosis and treatment. The manufacturer discontinued Geref commercially in the 2000s; it wasn't pulled for safety reasons. Today sermorelin is available through licensed compounding pharmacies with a prescription, not as an FDA-approved packaged drug.

Is mk-677 legal to buy in the US?

MK-677 isn't a controlled substance, but it's also not FDA-approved for human use. It's sold as a 'research chemical,' and the FDA has sent warning letters to companies marketing similar unapproved compounds for human consumption. There's no licensed pharmacy channel for it in the US the way there is for sermorelin.

Does mk-677 raise blood sugar more than sermorelin?

Clinical trials on MK-677 consistently show increased fasting glucose and HbA1c over sustained use, a well documented finding in trials of elderly and GH-deficient patients. Sermorelin's studied side effect profile doesn't show the same consistent glucose signal, though anyone with insulin resistance or diabetes risk should get monitored regardless of which one they choose.

What's the difference between sermorelin and hgh?

Sermorelin stimulates your own pituitary to release GH, preserving natural feedback loops and pulsatility. HGH is the actual hormone injected directly, bypassing the pituitary and overriding those feedback mechanisms. HGH produces stronger, faster effects but carries more risk of insulin resistance, joint pain, and edema at replacement or supraphysiologic doses.

Why was geref (sermorelin) discontinued?

The manufacturer discontinued Geref for commercial reasons in the 2000s, not because of an FDA safety action or recall. This is a key distinction: sermorelin has real FDA approval history behind it, unlike MK-677, which has never been approved as a drug anywhere.

Does sermorelin cause water retention like mk-677?

Water retention and facial puffiness are commonly reported in MK-677 Reddit threads, consistent with its stronger GH/IGF-1 stimulation. Sermorelin users report this far less often, likely because its milder, self-limiting mechanism produces smaller, more gradual GH pulses rather than a large sustained increase.

Can mk-677 or sermorelin help you lose fat?

Neither has strong controlled trial evidence for fat loss in healthy adults. Existing data comes mostly from GH-deficient or frail elderly populations, not healthy people optimizing body composition. Diet, resistance training, and sleep remain the best-documented levers; treat either compound as a possible minor assist, not a fat-loss solution.

Is it safer to get sermorelin from a prescriber than mk-677 online?

Yes, meaningfully so. Sermorelin requires a prescription and is dispensed through licensed, state-regulated compounding pharmacies with pharmacist oversight. MK-677 sold online as a research chemical has no manufacturing oversight, no verified purity standards, and no prescriber accountability in the supply chain.

How much does sermorelin cost compared to mk-677?

Sermorelin through a compounding pharmacy typically runs roughly $150 to $400 a month depending on dose and provider. MK-677 from gray-market sellers is often cheaper, roughly $30 to $100 a month, but that lower price reflects the total absence of pharmacy-grade oversight, not necessarily a bargain.

Sources

1. StatPearls (NCBI Bookshelf), Sermorelin, PMID 32491625: Sermorelin's short half-life of approximately 10-20 minutes
2. U.S. Food and Drug Administration, Drugs@FDA database, Geref NDA 019826: Geref (sermorelin) FDA approval history and discontinuation status
3. Sinha DK et al., Ibutamoren (MK-677) mechanism review, PMID 32148686: MK-677 acts as a ghrelin receptor agonist stimulating GH and IGF-1 release
4. Nass R et al., Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults, Annals of Internal Medicine, PMID 18711156: MK-677 raises fasting glucose and HbA1c over sustained clinical trial use
5. Copinschi G et al., Effects of a 7-day treatment with MK-677 on sleep, PMID 9231160: Modest increases in slow-wave sleep reported with ghrelin mimetic compounds
6. U.S. Food and Drug Administration, MedWatch adverse event reporting program: MedWatch is the FDA's formal system for tracking drug adverse events, unlike informal forum self-report